GIP and obesity disorder: Although the role of GIP in fat metabolism may seem contradictory to its ability to reduce fat mass, recent views suggest GIPR agonism supports healthy WAT expansion by clearing triglycerides and preventing lipotoxicity, alongside its ability to reduce fat mass through lower food intake, and thereby reduces insulin resistance and other obesity-related comorbidities [80].